Evaluating the CellSearch CMMC Assay for Non-Invasive Longitudinal MRD Monitoring
Powell, S.; Bui, T.; Gullipalli, D.; LaCava, M.; Jones, S. M.; Hansen, T.; Kuhr, F.; Swat, W.; Simandi, Z.
Show abstract
Current clinical management of multiple myeloma (MM) relies on bone marrow (BM) biopsies for minimal residual disease (MRD) assessment. While BM biopsies are the gold standard, their invasive nature and potential to miss extramedullary or patchy disease necessitate sensitive, non-invasive liquid biopsy platforms. In this study, we evaluated the analytical performance of the CellSearch CMMC assay to determine its utility for deep-MRD monitoring. Using a standard 4 mL whole blood input, the assay achieves a WBC-normalized sensitivity of 2.45 x 10-7, supported by a limit of quantitation of 5 cells per run. Given this high analytical sensitivity, the assay provides a robust negative predictive value, rendering false-negative findings highly unlikely in populations with detectable peripheral disease. These findings characterize the CellSearch CMMC assay as a highly sensitive, analytically validated platform for non-invasive deep-MRD level longitudinal surveillance monitoring. When integrated into a clinical workflow that accounts for its specificity profile, the platform offers a patient-friendly complement to serial BM biopsies, with the potential to reduce their frequency in appropriate clinical contexts.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Overcoming fixation and permeabilization challenges in flow cytometry by optical barcoding and multi-pass acquisition 93%
- Cleanet: robust doublet detection in cytometry data based on protein expression patterns 91%
- DeepIFC: virtual fluorescent labeling of blood cells in imaging flow cytometry data with deep learning 91%
Similar papers in this journal
Similar papers in this journal
- Comparing the value of mono- versus coculture for high-throughput compound screening in hematological malignancies 89%
- Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors 89%
- Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma 89%
Similar papers in this journal
- COMPARE, an ultra-fast and robust suite for multiparametric screening, identifies phenotypic drug responses in acute myeloid leukemia 91%
- Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy 91%
- Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay 91%
Similar papers in this journal
- Deep Learning-Enabled Point-Of-Care Sensing Using Multiplexed Paper-Based Sensors 89%
- High-Sensitivity Pan-Cancer AI Assessment of Lymph Node Metastasis via Uncertainty Quantification 87%
- Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis 86%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.